HealthZealand, Roche obesity drug helps patients lose up to 9.2% in mid-stage trial
Zealand Pharma said Wednesday that its experimental drug, being developed with Roche, helped people who are overweight or obese and have type 2 diabetes lose as much as 9.2% of their body weight in a mid-stage trial.
Zealand, Roche obesity drug helps patients lose up to 9.2% in mid-stage trial
